Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
|
US |
|
T
|
Tri Chemical Laboratories Inc
F:22E
|
JP |
|
Orthex Oyj
F:4QU
|
FI |
Intrinsic Value
The intrinsic value for
Kalvista Pharmaceuticals Inc (KALV) under the Base Case is 27.27 USD.
Compared with the current market price of 26.95 USD, the stock appears
Undervalued by 1% .
DCF suggests undervaluation, while multiples suggest overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Kalvista Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Kalvista Pharmaceuticals Inc
Earnings Waterfall
Kalvista Pharmaceuticals Inc
The intrinsic value for
Kalvista Pharmaceuticals Inc (KALV) under the Base Case is 27.27 USD.
Compared with the current market price of 26.95 USD, the stock appears Undervalued by 1% .